作者: Winson Y. Cheung , Geoffrey Liu
DOI: 10.1016/J.GTC.2009.01.009
关键词:
摘要: Investigations into inherited genetic variations in the DNA code (known as polymorphisms) field of oncology have provided preliminary support for an association with cancer risks and outcomes. Early studies highlighted several genes this potential predictive prognostic power. However, these had methodological limitations produced inconsistent results, making impractical yet routine evaluation such polymorphisms general clinical practice. Continued research area is essential if we are to be able soon use better select patients targeted anticancer interventions. This review discusses role their esophageal risk prognosis. The article also highlights future directions new, emerging molecular epidemiology.